Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

EPI obtains SBIR to identify protein biomarkers of breast cancer metastasis
June 2008
SHARING OPTIONS:

GAITHERSBURG, Md.Expression Pathology Inc. (EPI) announced last month it has been awarded a $148,000 Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to employ its proprietary tissue microproteomics technologies to identify protein biomarkers of metastasis in primary breast cancer. EPI's Liquid Tissue sample preparation and Director laser microdissection will enable in-depth mass spectrometry based proteomic profiling of archived formalin-fixed tissue with detailed patient histories, the company said.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.